Skip to main content
EnglishEnglish
EnglishEnglishArabicArabicChinese (Simplified)Chinese (Simplified)FrenchFrenchGermanGermanHindiHindiPortuguesePortugueseRussianRussianSpanishSpanishSwahiliSwahili

Header

  • Contact us
Home The Task Force for Global Health logo
  • https://twitter.com/GlobalHep
  • https://www.facebook.com/GlobalHep/
  • https://vimeo.com/globalhep
Donate
Add a Program
Add a Program
Profile
Logout

Main navigation

  • About
    • Who we are
    • What we do
    • Our team
    • Technical Advisory Board
    • Executive Board
    • Donor Acknowledgements
  • Programs
    • Programs search
  • Data dashboards
  • Evidence base
    • All evidence (search)
      • Evidence Base Methodology
    • Action plans
    • Hepatitis B Birth Dose Vaccine
      • Synthesis Brief of Hepatitis B Birth Dose Evidence Base
    • HCV Testing
    • COVID-19
      • Clinical Liver Disease COVID-19 special series
        • The COVID-19 Pandemic: An Epidemiologic, Public Health, and Clinical Brief
        • Synthesis of Liver Associations Recommendations for Hepatology and Liver Transplant Care During the COVID-19 Pandemic
      • COVID-19 and Liver Disease Synthesis
    • Innovations in Hepatitis Elimination (CLD Series)
      • Author Interviews
      • Introduction to Series
      • Past Publications
      • Author Guidance
  • Resources
    • Hepatitis Elimination Help Desk
    • Search resources
  • Webinars
    • Hep Test
    • Strategic Information Collaborative
    • HepB Birth Dose Introduction in AFRO
    • Innovations in Hepatitis Elimination
    • NIH Research Advancing Hepatitis Elimination
  • Elimination champions
    • Elimination Champions
    • Nominations for Elimination Champions
  • News
    • News search
  1. Home
  2. Evidence base
  3. Evidence base search

Evidence base articles search

The evidence base was developed using rigorous review methods for the identification and quality assessment of eligible systematic reviews and guideline and policy documents. In response to identified global research priorities, the evidence base currently presents characteristics of interventions to inform implementation of hepatitis B birth dose and hepatitis B and C action plans. Updates to the evidence base are planned to address subsequent priorities.

Edit

Evidence base search

Filter

  • (-) HCV testing
  • Hepatitis C
  • HCV testing and linkage to Care
  • Screening and diagnosis
  • Testing
  • (-) Blood transfusion recipients
  • Cross-sectional
  • Pakistan
  • Laboratory-based antibody test
  • Laboratory-based antibody test,Laboratory-based PCR/RNA (confirmatory) test
  • Laboratory-based PCR/RNA (confirmatory) test
Displaying 1 - 1 of 1
  • Prevalence of Hepatitis B and Hepatitis C in transfusion dependent thalassemia patients

    2018
    Medical Forum Monthly

    29

    76-79

Contact us

globalhep [at] taskforce.org

Tel: +1-404-371-0466

 

Photos on home page by Tayvessa Wilson, Conor Ashleigh, and Zunaid Murshed Paiker

Support us

Donate

Follow us

  • https://twitter.com/GlobalHep
  • https://www.facebook.com/GlobalHep/
  • https://vimeo.com/globalhep

Sign up to our newsletter

<

Footer

  • Contact
© 2019 - 2021 Coalition for Global Hepatitis Elimination
Website by Manta Ray Media
q